Rating the quality of evidence for clinical practice guidelines.
This article describes the system for rating the quality of medical evidence developed and used during creation of the Agency for Health Care Policy and Research-sponsored heart failure guideline. Previous approaches to rating evidence were not designed for use in the setting of clinical practice guidelines. The present system is based on the tenet that flaws in research design are serious to the extent they threaten the validity of the results of studies. A taxonomy of major and minor flaws based on that tenet was developed for randomized controlled trials and for cohort and medical registry studies. The use of the system is described in the context of two difficult clinical issues considered by the Panel: the role of coronary artery revascularization and the use of metoprolol.
Hadorn
D C
DC
Health Science Program, Rand, Santa Monica, California, USA.
Baker
D
D
Hodges
J S
JS
Hicks
N
N
D015982:Bias; D017410:Practice Guidelines as Topic / Q000592:standards*; D012107:Research Design